Questions and/or comments about Corn Lab and its activities may be addressed to:
The Corn Lab develops and uses next-generation genome editing and regulation technologies. We work on both fundamental biological discovery and potential therapies for human genetic diseases. Our focus is the mechanisms by which cells repair their DNA, maintain and differentiate hematopoietic stem cells, and use ubiquitin signaling to propagate cellular signals. Through technology development, mechanistic cellular biochemistry, and translational projects, we are working to unravel complex cellular phenotypes to further biological understanding and improve human health.
Our work is supported by the Swiss National Science Foundation, ETH Zurich, the NCCR RNA & Disease, the California Institute for Regenerative Medicine, the Fanconi Anemia Research Fund, and the Bill and Melinda Gates Foundation.